HIVe Home
HIV VACCINE ELECTRONIC (E) RESOURCE
ID#: PAR-11-056     Posted: 7 Mar 2012
NIAID Resource Related Research Projects for AIDS, Allergy, Immunology and Transplantation (R24)
Deadline: 25 May 2012
Apply Here
Type of Grant: Other
Topics/Fields of Support: Other
National Institute of Allergy and Infectious Diseases, NIH, HHS

The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. NIAID is one of the 27 Institutes and Centers of the National Institutes of Health (NIH). NIH, like the Centers for Disease Control and Prevention (CDC), is part of the U. S. Department of Health and Human Services (HHS). NIH is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, please visit NIH (www.nih.gov).


Visit web site

DETAILS

This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID) invites submission of investigator-initiated Resource-Related Research Projects (R24) applications.  These applications are limited to the research priorities of the Division of AIDS (DAIDS), and the Division of Allergy, Immunology and Transplantation (DAIT). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified.  Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID. It is anticipated that the request for resource support through the R24 mechanism will occur on an infrequent basis and only in circumstances where other mechanisms of support from the NIAID are not appropriate.

The proposed applications must address scientific areas relevant to the specific parts of the NIAID mission including the biology, pathogenesis, and host response to HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and research to develop vaccines, therapeutics, and diagnostics to prevent and treat HIV, immune-mediated, and allergic diseases.

ELIGIBILITY

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Project Director/Principal Investigator (PD/PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the PHS398 Application Guide.

CONTACT INFORMATION

Application Submission Contacts

GrantsInfo (Questions regarding application instructions and process, finding NIH grant resources)
Telephone 301-435-0714
TTY 301-451-5936
Email: GrantsInfo@nih.gov

eRA Commons Help Desk(Questions regarding eRA Commons registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939
Email: commons@od.nih.gov